Clinical Trial Update: Crossover Study From Macitentan or Bosentan Over to Ambrisentan [Phase 4]

View source ↗

Summary

A phase 4 crossover study evaluating switching from macitentan or bosentan to ambrisentan in pulmonary arterial hypertension has been terminated with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Ambrisentan (Ambrisentan)
• Bosentan (Bosentan)
• Macitentan (macitentan)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: TERMINATED | Results posted: 2019-04-08